Cyient Limited Grants 1.95 Lakh Stock Options to Associates Under Employee Stock Option Plans

Cyient Limited has announced the grant of 1,94,700 stock options to company associates under its various employee stock option plans. The Leadership, Nomination and Remuneration Committee approved this allocation on January 22, 2026, as communicated to the stock exchanges.

Stock Option Allocation Details

The company distributed the stock options across three distinct employee stock option plans, with varying allocations based on the specific scheme parameters.

Plan Name	Options Granted
Associate Restricted Stock Units Scheme 2020	79,700
Associate Stock Option Plan 2021	95,000
Associate Stock Option Plan 2023	20,000
Total Options Granted	1,94,700

Plan-wise Distribution

The Associate Stock Option Plan 2021 received the highest allocation with 95,000 options, representing approximately 48.8% of the total grant. The Associate Restricted Stock Units Scheme 2020 was allocated 79,700 options, accounting for about 40.9% of the total distribution. The newest plan, Associate Stock Option Plan 2023, received 20,000 options, comprising roughly 10.3% of the overall grant.

Corporate Communication

Cyient Limited formally notified both BSE Limited and the National Stock Exchange of India about this stock option grant through official correspondence. The company trades under scrip code 532175 on BSE and CYIENT on NSE. Deputy Company Secretary Ravi Kumar Nukala signed the communication on behalf of the company.

This stock option grant demonstrates Cyient's ongoing commitment to employee incentivization and retention through equity participation programs across multiple employee stock option schemes.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.00%	-3.53%	-2.00%	-11.59%	-34.54%	+123.40%

Cyient Limited has informed stock exchanges about the resignation of Ms. Matangi Gowrishankar as Independent Director, effective January 22, 2026. The company filed the intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Ms. Matangi Gowrishankar (DIN: 01518137) tendered her resignation as Independent Director citing personal reasons. The resignation became effective on January 22, 2026, following the close of the board meeting held on the same day.

Parameter:	Details
Effective Date:	January 22, 2026
Time of Occurrence:	15:45 hrs
Reason:	Personal reasons
Service Period:	Nearly 7 years

Impact on Board Composition

Following her resignation, Ms. Gowrishankar will cease to hold several key positions within the Cyient group:

Chairperson of Leadership, Nomination and Remuneration Committee of Cyient Limited
Board member of Cyient Inc. (material subsidiary)
Board member of Cyient Europe Limited (material subsidiary)

In her resignation letter dated January 21, 2026, Ms. Gowrishankar expressed gratitude for the opportunity to serve alongside distinguished industry leaders and described her tenure as a "rich and rewarding experience."

Other Board Positions

Ms. Gowrishankar currently serves as Independent Director on several other listed entities with various committee responsibilities:

Listed Entity:	Committee	Role
Greenlam Industries Limited	Audit Committee	Member
	Nomination and Remuneration Committee	Member
	Corporate Social Responsibility Committee	Chairperson
Akums Drugs and Pharmaceuticals Limited	Audit Committee	Member
	Nomination and Remuneration Committee	Chairperson
	Risk Management Committee	Member
Gujarat Pipavav Port Limited	Audit Committee	Member
	Nomination and Remuneration Committee	Chairperson
	Stakeholder Relationship Committee	Member
IDFC First Bank Limited	Nomination and Remuneration Committee	Chairperson
	Stakeholder Relationship Committee	Member
	Corporate Social Responsibility Committee	Member
Cohance Lifesciences Limited	Nomination and Remuneration Committee	Chairperson
	Corporate Social Responsibility Committee	Member

Regulatory Compliance

The company has fulfilled all disclosure requirements under SEBI regulations and stock exchange circulars. Ms. Gowrishankar confirmed in her resignation letter that there are no material reasons for her resignation other than the personal reasons mentioned. The resignation information has been made available on the company's website at www.cyient.com as per regulatory requirements.